UNSPSC 51182426: Cinacalcet

This classification denotes a malignancy-associated hypercalcemia inhibitor with the molecular formula C22H22F3N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UAZ6V7728S, chemically known as 1-naphthalenemethanamine, a-methyl-n-(3-(3-(trifluoromethyl)phenyl)propyl)-, (ar)- but generally known as cinacalcet, which bears US NIH Compound Identifier 156419. European Medicines Agency schedules Cinacalcet in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20068.

UNSPSC 51182426 Cinacalcet, a Commodity code, covers pharmaceutical products supplied through state and local cooperative purchasing agreements to government healthcare facilities and programs. State and local governments procure cinacalcet and similar generic multi-source pharmaceuticals through cooperative purchasing vehicles administered at the state level, typically bundled with over-the-counter products into master agreements that serve multiple jurisdictions and member agencies. Issuing bodies are primarily state purchasing offices operating multistate cooperatives; the Minnesota Department of Administration's Office of State Procurement administers the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), which is the primary known buyer in recent activity and extends purchasing access to participating state agencies and local government facilities across multiple states including Oregon.

MMCAP issued a Request for Proposal on January 20, 2026, with proposals due March 26, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and OTC products effective July 1, 2026. The procurement requires vendors to supply products through three authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co.), maintain compliance with current Good Manufacturing Practices and the Drug Supply Chain Security Act, and submit pricing in formats including flat price, net price, or WAC-minus structures, with price competitiveness weighted at 75 percent of evaluation criteria. Vendors must carry commercial general liability insurance of $5 million per occurrence, network security and privacy liability of $2 million, and professional liability of $2 million. The contract term is two years for new vendors with optional extensions, and vendors are subject to performance penalties of $200 to $1,500 per violation for late reporting, missed timelines, or improper trade denials. Specific award values and budget ranges are not disclosed in the solicitation.